Featured Research

from universities, journals, and other organizations

MIT Study May Lead To Powerful New Painkillers

Date:
April 5, 2002
Source:
Massachusetts Institute Of Technology
Summary:
New information on a cellular messenger may lead to powerful new painkilling drugs, Massachusetts Institute of Technology researchers recently reported online in the journal Psychopharmacology.

CAMBRIDGE, Mass. — New information on a cellular messenger may lead to powerful new painkilling drugs, Massachusetts Institute of Technology researchers recently reported online in the journal Psychopharmacology.

Blocking a common signaling messenger between cells might shut down the chronic pain and inflammation that plagues millions, says author Lisa A. Teather, postdoctoral associate in the MIT Department of Brain and Cognitive Sciences.

More than 100 million North Americans suffer from chronic pain, and around half of these people are partially or totally disabled by it. Inflammation may also be involved in the pathology of diseases such as Alzheimer’s.

Teather studies platelet-activating factor (PAF), identified as a blood-clotting agent in the 1970s. It was later found to cause the buildup of prostaglandins, derivatives of fatty acids found in most body tissues. Excess prostaglandins are associated with chronic pain and inflammation.

AN INSIDE STORY

PAF affects two kinds of receptors. Teather believes that receptors within cells regulate prostaglandin production. Drugs such as ibuprofen and aspirin relieve pain by blocking the formation of prostaglandins.

Teather and co-authors Richard J. Wurtman, C. H. Green Distinguished Professor in Brain and Cognitive Sciences and director of MIT’s Clinical Research Center; and Jane E. Magnusson of the Department of Clinical Neurosciences at the University of Calgary, found that drugs that interfere with PAF’s action block prostaglandin production and diminish pain and inflammation.

Although these drugs are not now used to treat inflammation or pain, one is in the herbal supplement gingko biloba. MIT has filed for patents on blocking PAF as a means for mediating inflammatory responses and alleviating pain.

In the study, rats that were given drugs known to block PAF action exhibited significantly less pain response than did rats that did not get the drugs.

Although the researchers do not yet have any data on PAF in humans, they believe that blocking PAF might be effective in the treatment of certain forms of acute and chronic pain.

CHECKING IMMUNE RESPONSE

"PAF controls many of the usual suspects in the inflammatory reaction," Teather said. Out-of-control inflammation is an indication of an immune response gone awry. At a molecular level, an overactive immune system leads to neurotoxicity, which may be a culprit in some neurological diseases.

A future painkiller that regulates PAF also could be useful in conjunction with morphine, which quickly loses its effectiveness in patients with chronic pain.

This study was supported in part by grants from the National Institutes of Mental Health and the Center for Brain Sciences and Metabolism Charitable Trust.


Story Source:

The above story is based on materials provided by Massachusetts Institute Of Technology. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts Institute Of Technology. "MIT Study May Lead To Powerful New Painkillers." ScienceDaily. ScienceDaily, 5 April 2002. <www.sciencedaily.com/releases/2002/04/020402073407.htm>.
Massachusetts Institute Of Technology. (2002, April 5). MIT Study May Lead To Powerful New Painkillers. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2002/04/020402073407.htm
Massachusetts Institute Of Technology. "MIT Study May Lead To Powerful New Painkillers." ScienceDaily. www.sciencedaily.com/releases/2002/04/020402073407.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins